Close

Amarin (AMRN) Says FDA Decision on ANCHOR SPA Delayed

January 15, 2014 4:06 PM EST Send to a Friend
Amarin Corp Plc (NASDAQ: AMRN) announced today that the Division of Metabolism and Endocrinology Products (DMEP) within the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login